Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;25(5):671-675.
doi: 10.1016/j.jsps.2016.10.002. Epub 2016 Oct 17.

Comparative assessment of saliva and plasma for drug bioavailability and bioequivalence studies in humans

Nasir M Idkaidek  1
Affiliations

Comparative assessment of saliva and plasma for drug bioavailability and bioequivalence studies in humans

Nasir M Idkaidek. Saudi Pharm J. 2017 Jul.

Abstract

Aims: To study the pharmacokinetics of selected drugs in plasma and saliva matrixes in healthy human volunteers, and to suggest using non-invasive saliva sampling instead of plasma as a surrogate in bioavailability and bioequivalence (BA/BE) studies. Methods: Four different pilot BA/BE studies were done in 12-18 healthy humans. Saliva and plasma samples were collected for 3-5 half life values of metformin, tolterodine, rosuvastatin, and paracetamol after oral dosing. Saliva and plasma samples were assayed using LC-MSMS, and then pharmacokinetic parameters were calculated by non-compartmental analysis using Kinetica program. Effective intestinal permeability (Peff) values were also optimized to predict the actual average plasma profile of each drug by Nelder-Mead algorithm of the Parameter Estimation module using SimCYP program. Results: All studied drugs showed salivary excretion with strong correlation coefficients between saliva and plasma concentrations. The optimized Peff ranged 1.44-68.3 × 10-4 cm/s for the drugs under investigation. Saliva/plasma concentrations ratios ranged 0.17-1.5. Inter and intra individual variability of primary pharmacokinetic parameters in saliva matrix was either close to or higher than plasma matrix. This requires larger sample size in saliva studies for some drugs. Conclusion: Our results suggest that there is a potential in BA/BE studies for saliva to be considered as a surrogate for plasma concentration, which goes along with drug regulations. The use of saliva instead of plasma in such studies makes them non-invasive, easy and with a lower clinical burden.

Keywords: Bioequivalence; Pharmacokinetics; SECS; Saliva.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Paracetamol plasma and saliva mean profiles & correlations.
Figure 2
Figure 2
Metformin plasma and saliva mean profiles & correlations.
Figure 3
Figure 3
Tolterodine plasma and saliva mean profiles & correlations.
Figure 4
Figure 4
Rosuvastatin plasma and saliva mean profiles & correlations.
See this image and copyright information in PMC

References

    1. Amidon G.L., Lennernäs H., Shah V.P., Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995;12(3):413–420. - PubMed
    1. Food and Drug Administration, 2003. Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products—General Considerations. Division of Drug Information, Center for Drug Evaluation and Research, Food and Drug Administration, 5600 Fishers Lane Rockville, MD 20857, USA, March.
    1. Gorodischer R., Koren G. Salivary excretion of drugs in children: theoretical and practical issues in therapeutic drug monitoring. Dev. Pharmacol. Ther. 1992;19(4):161–177. - PubMed
    1. Idkaidek Nasir, Arafat Tawfiq. Saliva versus plasma pharmacokinetics: theory and application of a salivary excretion classification system. Mol. Pharm. 2012;9:2358–2363. - PubMed
    1. Idkaidek N., Arafat T. Saliva vs. plasma bioequivalence of paracetamol in humans: validation of class I drugs of the salivary excretion classification system. Drug Res. 2014;64(10):559–562. - PubMed

LinkOut - more resources